These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 4148416)

  • 1. Susceptibility of recently isolated pathogenic bacteria to trimethoprim and sulfamethoxazole separately and combined.
    Bach MC; Finland M; Gold O; Wilcox C
    J Infect Dis; 1973 Nov; 128():Suppl:508-33 p. PubMed ID: 4148416
    [No Abstract]   [Full Text] [Related]  

  • 2. [Laboratory findings on a combination of trimethoprim and sulfamethoxazole].
    Legler F
    Dtsch Med Wochenschr; 1971 May; 96(19):823-4 passim. PubMed ID: 4396839
    [No Abstract]   [Full Text] [Related]  

  • 3. Susceptibility of common pathogenic bacteria to seven tetracycline antibiotics in vitro.
    Steigbigel NH; Reed CW; Finland M
    Am J Med Sci; 1968 Mar; 255():179-95. PubMed ID: 4384524
    [No Abstract]   [Full Text] [Related]  

  • 4. Trimethoprim-sulfamethoxazole: in vitro microbiological aspects.
    Bushby SR
    J Infect Dis; 1973 Nov; 128():Suppl:442-62 p. PubMed ID: 4585951
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the effect of hexetidine in vitro].
    Linzenmeier G
    Arzneimittelforschung; 1969 Feb; 19(2):164-7. PubMed ID: 4388760
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative in vitro activity of amoxicillin and ampicillin against bacteria isolated from ill children.
    Marks MI
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1137-44. PubMed ID: 4154827
    [No Abstract]   [Full Text] [Related]  

  • 7. Changing patterns of susceptibility of common bacterial pathogens to antimicrobial agents.
    Finland M
    Ann Intern Med; 1972 Jun; 76(6):1009-36. PubMed ID: 4402139
    [No Abstract]   [Full Text] [Related]  

  • 8. Analysis of in vitro antibacterial activities of the combination of trimethoprim and sulfamethoxazole on clinical isolates in Japan.
    J Infect Dis; 1973 Nov; 128():Suppl:502-7 p. PubMed ID: 4585955
    [No Abstract]   [Full Text] [Related]  

  • 9. Alterations in the sensitivity pattern after use of trimethoprim-sulfamethoxazole for two years in the treatment of urinary tract infections.
    Fruensgaard K; Korner B
    Chemotherapy; 1974; 20(2):97-101. PubMed ID: 4210895
    [No Abstract]   [Full Text] [Related]  

  • 10. Cephaloridine: antimicrobial activity and pharmacologic behavior.
    Kaplan K; Reisberg BE; Weinstein L
    Am J Med Sci; 1967 Jun; 253(6):667-74. PubMed ID: 4381751
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibacterial activity in vitro and in vivo of the trimethoprim-sulphamethoxazole combination].
    Renzini G; Ravagnan G; Bormioli P; D'Alessandro A
    Antibiotica; 1969 Dec; 7(4):250-68. PubMed ID: 5004706
    [No Abstract]   [Full Text] [Related]  

  • 12. [Present status of bacterial resistance to antibiotics and chemotherapeutic drugs and a tendency towards the development of resistance].
    Fritsche D; Schulz-Stübner A
    Dtsch Med Wochenschr; 1972 Dec; 97(51):1963-8. PubMed ID: 4404874
    [No Abstract]   [Full Text] [Related]  

  • 13. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
    Lebek G; Wiedmer E
    Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro antibacterial activity of minocycline and effect of agar medium utilized in its susceptibility testing.
    Washington JA; Yu PK; Martin WJ
    Appl Microbiol; 1970 Feb; 19(2):259-63. PubMed ID: 4392357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory and clinical evaluation of rifampicin.
    Atlas E; Turck M
    Am J Med Sci; 1968 Oct; 256(4):47-54. PubMed ID: 4387028
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental evaluation of the new cephalosporin antibiotic cephacetrile].
    Kradolfer F; Ahrens T; Gelzer J; Vischer W; Zimmermann W
    Arzneimittelforschung; 1974 Sep; 24(9b):1446-51. PubMed ID: 4154769
    [No Abstract]   [Full Text] [Related]  

  • 17. [Development of bacterial resistance against trimethoprim-sulfamethoxazole (Eusaprim)].
    Meyer-Rohn J; Liehr W
    Fortschr Med; 1974 Jan; 92(3):121-6. PubMed ID: 4206486
    [No Abstract]   [Full Text] [Related]  

  • 18. [Gentamicin. Brief review of current information].
    Modr Z; Hejzlar M
    Cas Lek Cesk; 1970 Apr; 109(17):347-51. PubMed ID: 4393373
    [No Abstract]   [Full Text] [Related]  

  • 19. [Bacteriological studies on penimepicycline].
    Nakazawa S; Ono N; Mekata I; Kawabe H; Nishino T
    Jpn J Antibiot; 1969 Feb; 22(1):16-20. PubMed ID: 4389008
    [No Abstract]   [Full Text] [Related]  

  • 20. [Modern data on the antibiotic sensitivity of the microflora that is an etiological factor in ENT diseases. II. The antibiotic sensitivity of pneumococci, meningococci, influenza bacilli, Klebsiella, enterobacteria, Pseudomonas aeruginosa and Proteus].
    Povolotskiĭ IaL
    Zh Ushn Nos Gorl Bolezn; 1979; (2):85-90. PubMed ID: 34945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.